Neuland Laboratories peers

Companies like Neuland Laboratorieslatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NEULANDLAB₹19,280.00

Neuland Laboratories Ltd.

· Pharma & Health
₹ CrorePeersDIVISLABLAURUSLABSNHNATCOPHARMLALPATHLABSAILIFECOHANCEASTERDMMcap ₹24,872 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
NEULANDLAB
FY26
DIVISLAB
FY26
LAURUSLABS
FY26
NH
FY26
Peer
Average
Valuation — at last close
P/E67.96×99.89×136.25×◆ 43.22×93.12× -27%
P/B13.27×15.28×22.86×◆ 7.72×15.29× -13%
EV/EBITDA43.02×73.43×69.50×◆ 23.11×55.35× -22%
Market Cap₹24,872 Cr₹2.56L Cr₹1.21L Cr₹35,038 Cr₹1.37L Cr -82%
Growth
Revenue CAGR 3Y19.31%10.78%4.09%◆ 20.39%11.75% +64%
Revenue CAGR 5Y16.64%8.67%7.19%◆ 25.05%13.64% +22%
Net Income CAGR 3Y◆ 30.57%12.09%3.91%9.94%8.65% +254%
Revenue YoY (latest Q)◆ 119.15%27.80%33.44%73.01%44.75% +166%
Net Income YoY (latest Q)◆ 962.40%65.50%124.27%16.50%68.76% +1300%
Profitability
EBITDA Margin28.40%◆ 32.59%26.09%20.47%26.38% +8%
Net Income Margin17.99%◆ 24.32%13.07%10.21%15.87% +13%
Return on Common Equity◆ 21.42%16.19%18.19%19.74%18.04% +19%
Return on Capital Employed◆ 24.54%17.80%20.48%13.94%17.41% +41%
Return on Assets◆ 14.25%13.89%8.97%8.17%10.34% +38%
Credit & Quality
Total Debt/Equity0.10×◆ 0.00×0.44×1.07×0.50× -80%
Interest Coverage20.16×◆ 129.48×7.60×4.80×47.29× -57%
Scale — latest FY
Revenue / Total Income₹2,023 Cr₹10,560 Cr₹6,813 Cr₹7,896 Cr₹8,423 Cr -76%
Net Income₹364 Cr₹2,568 Cr₹890 Cr₹806 Cr₹1,421 Cr -74%
Total Assets₹2,930 Cr₹20,033 Cr₹10,511 Cr₹12,474 Cr₹14,340 Cr -80%
EPS₹283.71₹96.75₹16.47₹39.67₹50.96 +457%
Book Value per Share₹1,453.02₹632.49₹98.18₹222.02₹317.56 +358%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.